We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
10 Year Est. Return
AUM
$48.1M
AUM Growth
-$2.2M
Cap. Flow
-$9.4M
Cap. Flow %
-19.54%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NXTC icon
NextCure
NXTC
+$9.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDYA icon
1
IDEAYA Biosciences
IDYA
$3.54B
$37.3M 77.44%
2,660,713
NXTC icon
2
NextCure
NXTC
$20.8M
$9.14M 19%
69,870
-72,756
-51% -$9.4M
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
$1.71M 3.56%
115,545

Similar funds

Canaan Partners X's Q4 2020 Portfolio in Review

As of Q4 2020, Canaan Partners X held 3 positions worth $48.1M, down 4.4% from $50.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners X withdrew a net $9.4M in Q4 2020, reducing 1 holding. Its largest reduction was NextCure, cutting an estimated $9.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Canaan Partners X's biggest Q4 2020 reduction was NextCure, cutting an estimated $9.4M.
  • Canaan Partners X's ten largest holdings make up 100% of its $48.1M portfolio in Q4 2020.
  • Canaan Partners X opened 0 new positions and closed 0 in Q4 2020.
  • Canaan Partners X's portfolio value fell 4.4% quarter-over-quarter to $48.1M.

Based on Canaan Partners X's 13F filing for Q4 2020, filed 2 Feb 2021.